Put companies on watchlist
MediClin AG
ISIN: DE0006595101
WKN: 659510
Curious about what AI knows about Mediclin? Just one click more
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

MediClin AG · ISIN: DE0006595101 · EQS - Company News (58 News)
Country: Germany · Primary market: Germany · EQS NID: 1864689
21 March 2024 04:56PM

MEDICLIN invites you to the virtual press conference on the financial statements for the year 2023


EQS-News: MediClin AG / Key word(s): Conference/Miscellaneous
MEDICLIN invites you to the virtual press conference on the financial statements for the year 2023

21.03.2024 / 16:56 CET/CEST
The issuer is solely responsible for the content of this announcement.


Offenburg, March 21, 2024

MEDICLIN invites you to the virtual press conference on the financial statements for the year 2023

MEDICLIN (Ticker: MED; WKN 659 510) invites you to the virtual press conference on the financial statements for the year 2023. The event will take place on

March 26, 2024 at 11.00 a.m. (CET).

The Management Board of MEDICLIN will report on the 2023 financial year, current developments at MEDICLIN and the outlook for 2024 in a webcast.

Following the presentation by the Management Board, you will have the opportunity to ask questions. The presentation will be held in German.

To participate in the press conference, please register at the following link:

MEDICLIN virtual press conference on the financial statements for the year 2023

You will then receive the link to the webcast and the dial-in details for the telephone connection.

Please dial in 10 minutes before the start of the event.

The replay of the webcast (without the Q&A session) will be available on the MEDICLIN website soon after the press conference.

We look forward to your participation.

For more information:
Investor Relations
Ender Gülcan, CIIA, CESGA
Head of Investor Relations and Sustainability
Phone +49 781/488-326
ender.guelcan@mediclin.de

MEDICLIN Aktiengesellschaft
Okenstraße 27
77652 Offenburg
Germany

About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510)
MEDICLIN includes 32 clinics, six care facilities and ten medical care centers. The Group has around 8,300 beds/care places and employs around 10,000 people. In a strong network, MEDICLIN offers the patient integrative care from the first visit to the doctor through the operation and subsequent rehabilitation to outpatient aftercare. Doctors, therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people in need of care according to their individual needs and personal needs.

MEDICLIN ─ a company of the Asklepios Group
 


21.03.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-326
Fax: +49 (0)781 488-184
E-mail: ender.guelcan@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1864689

 
End of News EQS News Service

1864689  21.03.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1864689&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - MediClin AG
Smart analysis and research tools can be found here.
MIC: XETR

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.